X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs TTK HEALTHCARE - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK TTK HEALTHCARE MERCK/
TTK HEALTHCARE
 
P/E (TTM) x 51.1 18.9 270.0% View Chart
P/BV x 7.7 4.9 158.2% View Chart
Dividend Yield % 0.4 0.6 73.8%  

Financials

 MERCK   TTK HEALTHCARE
EQUITY SHARE DATA
    MERCK
Dec-17
TTK HEALTHCARE
Mar-14
MERCK/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,358663 204.6%   
Low Rs933399 233.8%   
Sales per share (Unadj.) Rs665.0535.6 124.2%  
Earnings per share (Unadj.) Rs56.615.9 354.8%  
Cash flow per share (Unadj.) Rs72.520.0 361.9%  
Dividends per share (Unadj.) Rs15.004.00 375.0%  
Dividend yield (eoy) %1.30.8 173.9%  
Book value per share (Unadj.) Rs441.7137.6 321.0%  
Shares outstanding (eoy) m16.607.77 213.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.0 173.6%   
Avg P/E ratio x20.233.3 60.8%  
P/CF ratio (eoy) x15.826.5 59.6%  
Price / Book Value ratio x2.63.9 67.2%  
Dividend payout %26.525.1 105.7%   
Avg Mkt Cap Rs m19,0114,127 460.6%   
No. of employees `0001.51.7 90.4%   
Total wages/salary Rs m1,696607 279.7%   
Avg. sales/employee Rs Th7,150.02,436.7 293.4%   
Avg. wages/employee Rs Th1,098.7355.2 309.4%   
Avg. net profit/employee Rs Th608.272.5 838.5%   
INCOME DATA
Net Sales Rs m11,0404,162 265.3%  
Other income Rs m24061 391.7%   
Total revenues Rs m11,2794,223 267.1%   
Gross profit Rs m1,376197 698.2%  
Depreciation Rs m26432 832.8%   
Interest Rs m030 0.0%   
Profit before tax Rs m1,352197 687.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m58373 800.5%   
Profit after tax Rs m939124 757.9%  
Gross profit margin %12.54.7 263.2%  
Effective tax rate %43.137.0 116.5%   
Net profit margin %8.53.0 285.7%  
BALANCE SHEET DATA
Current assets Rs m7,5231,629 461.9%   
Current liabilities Rs m2,2531,058 213.0%   
Net working cap to sales %47.713.7 348.0%  
Current ratio x3.31.5 216.9%  
Inventory Days Days5230 175.2%  
Debtors Days Days4134 120.7%  
Net fixed assets Rs m1,240556 222.8%   
Share capital Rs m16678 213.6%   
"Free" reserves Rs m7,167878 816.0%   
Net worth Rs m7,3331,069 685.7%   
Long term debt Rs m0159 0.0%   
Total assets Rs m9,9122,399 413.1%  
Interest coverage xNM7.6-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.11.7 64.2%   
Return on assets %9.56.4 147.8%  
Return on equity %12.811.6 110.5%  
Return on capital %20.818.5 112.5%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m1,01533 3,083.9%   
Fx outflow Rs m3,04363 4,815.0%   
Net fx Rs m-2,028-30 6,695.3%   
CASH FLOW
From Operations Rs m537127 423.9%  
From Investments Rs m-476-146 326.2%  
From Financial Activity Rs m-22022 -1,003.7%  
Net Cashflow Rs m-1603 -6,380.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 3.7 491.9%  
FIIs % 1.0 5.2 19.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 25.8 112.8%  
Shareholders   28,591 12,723 224.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  

Compare MERCK With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 425 Points Higher; Banking and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours and ended their day on a positive note. Gains were largely seen in the banking sector and energy sector.

Related Views on News

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Mar 26, 2019 03:35 PM

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS